Establishing a baseline incidence of adverse drug reactions in hospitalised oncology patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2000, v. 6, n. 2, p. 55, doi. 10.1191/107815500678816160
- By:
- Publication type:
- Article
Works matching IS 10781552 AND DT 2000 AND VI 6 AND IP 2
Results: 6
1
2
The impact of introducing pre-printed chemotherapy medication charts to a day chemotherapy unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2000, v. 6, n. 2, p. 64, doi. 10.1191/107815500678816179
- By:
- Publication type:
- Article
3
Reproducibility of treatment methodologies detailed in contemporary clinical trial reports.
- Published in:
- Journal of Oncology Pharmacy Practice, 2000, v. 6, n. 2, p. 50, doi. 10.1191/107815500678816188
- By:
- Publication type:
- Article
4
A multidisciplinary approach to ensure safety in the prescribing and administration of chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2000, v. 6, n. 2, p. 60, doi. 10.1191/107815500678816197
- By:
- Publication type:
- Article
5
The cost of blood transfusions in cancer patients: a reanalysis of a Canadian economic evaluation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2000, v. 6, n. 2, p. 37, doi. 10.1191/107815500678816205
- By:
- Publication type:
- Article
6
Docetaxel in hepatic impairment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2000, v. 6, n. 2, p. 43, doi. 10.1191/107815500678816214
- By:
- Publication type:
- Article